...
首页> 外文期刊>Experimental Eye Research >Edaravone is a free radical scavenger that protects against laser-induced choroidal neovascularization in mice and common marmosets
【24h】

Edaravone is a free radical scavenger that protects against laser-induced choroidal neovascularization in mice and common marmosets

机译:依达拉奉是一种自由基清除剂,可保护小鼠和普通mar猴免受激光诱导的脉络膜新生血管形成

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Choroidal neovascularization (CNV) is a main characteristic in exudative type of age-related macular degeneration (AMD). Our study aimed to evaluate the effects of edaravone, a free radical scavenger on laser-induced CNV. CNV was induced by laser photocoagulation to the subretinal choroidal area of mice and common marmosets. Edaravone was administered either intraperitoneally twice a day for 2 weeks or intravenously just once after laser photocoagulation. The effects of edaravone on laser-induced CNV were evaluated by fundus fluorescein angiography, CNV area measurements, and the expression of 4-hydroxy-2-nonenal (4-HNE) modified proteins, a marker of oxidative stress. Furthermore, the effects of edaravone on the production of H2O2-induced reactive oxygen species (ROS) and vascular endothelial growth factor (VEGF)-induced cell proliferation were evaluated using human retinal pigment epithelium cells (ARPE-19) and human retinal microvascular endothelial cells, respectively. CNV areas in the edaravone-treated group were significantly smaller in mice and common marmosets. The expression of 4-HNE modified proteins was upregulated 3 h after laser photocoagulation, and intravenously administered edaravone decreased it. In in vitro studies, edaravone inhibited H2O2-induced ROS production and VEGF-induced cell proliferation. These findings suggest that edaravone may protect against laser-induced CNV by inhibiting oxidative stress and endothelial cell proliferation. (c) 2016 Elsevier Ltd. All rights reserved.
机译:脉络膜新生血管形成(CNV)是年龄相关性黄斑变性(AMD)渗出型的主要特征。我们的研究旨在评估依达拉奉(一种自由基清除剂)对激光诱导的CNV的影响。激光光凝诱导小鼠和普通mar猴视网膜下脉络膜区域产生CNV。依达拉奉每天两次腹膜内给药,持续2周,或者在激光光凝后一次静脉内给药。通过眼底荧光血管造影,CNV面积测量以及氧化应激标记物4-羟基-2-壬烯醛(4-HNE)修饰蛋白的表达,评估了依达拉奉对激光诱导的CNV的影响。此外,使用人视网膜色素上皮细胞(ARPE-19)和人视网膜微血管内皮细胞评估了依达拉奉对H2O2诱导的活性氧(ROS)产生和血管内皮生长因子(VEGF)诱导的细胞增殖的影响。 , 分别。依达拉奉治疗组的CNV面积在小鼠和普通V猴中明显较小。激光光凝后3 h,4-HNE修饰蛋白的表达上调,静脉注射依达拉奉可降低其表达。在体外研究中,依达拉奉抑制H2O2诱导的ROS产生和VEGF诱导的细胞增殖。这些发现表明依达拉奉可通过抑制氧化应激和内皮细胞增殖来保护免受激光诱导的CNV侵害。 (c)2016 Elsevier Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号